These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36817510)

  • 1. Chronic treatment with baicalein alleviates behavioural disorders and improves cerebral blood flow via reverting metabolic abnormalities in a J20 transgenic mouse model of Alzheimer's disease.
    Zhang L; Wong LR; Wong P; Shen W; Yang S; Huang L; Lim YA; Ho PC
    Brain Behav Immun Health; 2023 Mar; 28():100599. PubMed ID: 36817510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
    Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
    Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ameliorative effects of baicalein on an amyloid-β induced Alzheimer's disease rat model: a proteomics study.
    Wei D; Tang J; Bai W; Wang Y; Zhang Z
    Curr Alzheimer Res; 2014; 11(9):869-81. PubMed ID: 25274114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Electroacupuncture improves learning-memory ability possibly by suppressing apoptosis and down-regulating expression of apoptosis-related proteins in hippocampus and cerebral cortex in immature mice with Alzheimer's disease].
    Zhang SJ; Su SH; Gao JF
    Zhen Ci Yan Jiu; 2020 Aug; 45(8):611-6. PubMed ID: 32869569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay between Alzheimer's disease and global glucose metabolism revealed by the metabolic profile alterations of pancreatic tissue and serum in APP/PS1 transgenic mice.
    Liu X; Wang W; Chen HL; Zhang HY; Zhang NX
    Acta Pharmacol Sin; 2019 Oct; 40(10):1259-1268. PubMed ID: 31089202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reverting Metabolic Dysfunction in Cortex and Cerebellum of APP/PS1 Mice, a Model for Alzheimer's Disease by Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Agonist.
    Chang KL; Wong LR; Pee HN; Yang S; Ho PC
    Mol Neurobiol; 2019 Nov; 56(11):7267-7283. PubMed ID: 31016475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mulberry Fruit Extract Alleviates Cognitive Impairment by Promoting the Clearance of Amyloid-β and Inhibiting Neuroinflammation in Alzheimer's Disease Mice.
    Liu D; Du D
    Neurochem Res; 2020 Sep; 45(9):2009-2019. PubMed ID: 32488469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Cerebral Blood Volume under Normobaric Hyperoxia in the J20-hAPP Mouse Model of Alzheimer's Disease.
    Shabir O; Sharp P; Rebollar MA; Boorman L; Howarth C; Wharton SB; Francis SE; Berwick J
    Sci Rep; 2020 May; 10(1):7518. PubMed ID: 32371859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baicalein attenuates caspase-independent cells death via inhibiting PARP-1 activation and AIF nuclear translocation in cerebral ischemia/reperfusion rats.
    Li WH; Yang YL; Cheng X; Liu M; Zhang SS; Wang YH; Du GH
    Apoptosis; 2020 Jun; 25(5-6):354-369. PubMed ID: 32338336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurovascular coupling preserved in a chronic mouse model of Alzheimer's disease: Methodology is critical.
    Sharp PS; Ameen-Ali KE; Boorman L; Harris S; Wharton S; Howarth C; Shabir O; Redgrave P; Berwick J
    J Cereb Blood Flow Metab; 2020 Nov; 40(11):2289-2303. PubMed ID: 31760864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Berberine Improves Cognitive Impairment by Simultaneously Impacting Cerebral Blood Flow and β-Amyloid Accumulation in an APP/tau/PS1 Mouse Model of Alzheimer's Disease.
    Ye C; Liang Y; Chen Y; Xiong Y; She Y; Zhong X; Chen H; Huang M
    Cells; 2021 May; 10(5):. PubMed ID: 34064687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II, hypertension and angiotensin II receptor antagonism: Roles in the behavioural and brain pathology of a mouse model of Alzheimer's disease.
    Wiesmann M; Roelofs M; van der Lugt R; Heerschap A; Kiliaan AJ; Claassen JA
    J Cereb Blood Flow Metab; 2017 Jul; 37(7):2396-2413. PubMed ID: 27596834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral administration of methysticin improves cognitive deficits in a mouse model of Alzheimer's disease.
    Fragoulis A; Siegl S; Fendt M; Jansen S; Soppa U; Brandenburg LO; Pufe T; Weis J; Wruck CJ
    Redox Biol; 2017 Aug; 12():843-853. PubMed ID: 28448946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Cerebral Small Vessel Changes in AD Model Mice.
    Shibly AZ; Sheikh AM; Michikawa M; Tabassum S; Azad AK; Zhou X; Zhang Y; Yano S; Nagai A
    Biomedicines; 2022 Dec; 11(1):. PubMed ID: 36672558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and Pathological Benefit of Twendee X in Alzheimer's Disease Transgenic Mice with Chronic Cerebral Hypoperfusion.
    Liu X; Yamashita T; Shang J; Shi X; Morihara R; Huang Y; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1993-2002. PubMed ID: 31029568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioenergetic Impairment in Animal and Cellular Models of Alzheimer's Disease: PARP-1 Inhibition Rescues Metabolic Dysfunctions.
    Martire S; Fuso A; Mosca L; Forte E; Correani V; Fontana M; Scarpa S; Maras B; d'Erme M
    J Alzheimers Dis; 2016 Aug; 54(1):307-24. PubMed ID: 27567805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of Abca7 increases cerebral amyloid-β accumulation in the J20 mouse model of Alzheimer's disease.
    Kim WS; Li H; Ruberu K; Chan S; Elliott DA; Low JK; Cheng D; Karl T; Garner B
    J Neurosci; 2013 Mar; 33(10):4387-94. PubMed ID: 23467355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Untargeted metabolomics analysis of the hippocampus and cerebral cortex identified the neuroprotective mechanisms of Bushen Tiansui formula in an aβ
    Li H; Tan Y; Cheng X; Zhang Z; Huang J; Hui S; Zhu L; Liu Y; Zhao D; Liu Z; Peng W
    Front Pharmacol; 2022; 13():990307. PubMed ID: 36339577
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-Aβ antibodies incapable of reducing cerebral Aβ oligomers fail to attenuate spatial reference memory deficits in J20 mice.
    Mably AJ; Liu W; Mc Donald JM; Dodart JC; Bard F; Lemere CA; O'Nuallain B; Walsh DM
    Neurobiol Dis; 2015 Oct; 82():372-384. PubMed ID: 26215784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(ADP-ribose)polymerase-1 modulates microglial responses to amyloid β.
    Kauppinen TM; Suh SW; Higashi Y; Berman AE; Escartin C; Won SJ; Wang C; Cho SH; Gan L; Swanson RA
    J Neuroinflammation; 2011 Nov; 8():152. PubMed ID: 22051244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.